Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial by von Minckwitz, Gunter, Prof, Schneeweiss, Andreas, Prof, Loibl, Sibylle, Prof, Salat, Christoph, MD, Denkert, Carsten, Prof, Rezai, Mahdi, Prof, Blohmer, Jens U, Prof, Jackisch, Christian, Prof, Paepke, Stefan, MD, Gerber, Bernd, Prof, Zahm, Dirk M, MD, Kümmel, Sherko, MD, Eidtmann, Holger, MD, Klare, Peter, MD, Huober, Jens, Prof, Costa, Serban, Prof, Tesch, Hans, Prof, Hanusch, Claus, MD, Hilfrich, Jörn, Prof, Khandan, Fariba, MD, Fasching, Peter A, Prof, Sinn, Bruno V, MD, Engels, Knut, MD, Mehta, Keyur, MBA, Nekljudova, Valentina, PhD, Untch, Michael, Prof

Get full text

Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto—GBG 69): a randomised, phase 3 trial by Untch, Michael, Prof, Jackisch, Christian, Prof, Schneeweiss, Andreas, Prof, Conrad, Bettina, MD, Aktas, Bahriye, MD, Denkert, Carsten, Prof, Eidtmann, Holger, MD, Wiebringhaus, Hermann, MD, Kümmel, Sherko, MD, Hilfrich, Jörn, Prof, Warm, Mathias, Prof, Paepke, Stefan, MD, Just, Marianne, MD, Hanusch, Claus, MD, Hackmann, John, MD, Blohmer, Jens-Uwe, Prof, Clemens, Michael, Prof, Darb-Esfahani, Silvia, MD, Schmitt, Wolfgang Daniel, MD, Dan Costa, Serban, Prof, Gerber, Bernd, Prof, Engels, Knut, MD, Nekljudova, Valentina, PhD, Loibl, Sibylle, Prof, von Minckwitz, Gunter, Prof

Get full text

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study by Kuehn, Thorsten, Prof, Bauerfeind, Ingo, MD, Fehm, Tanja, Prof, Fleige, Barbara, MD, Hausschild, Maik, MD, Helms, Gisela, MD, Lebeau, Annette, MD, Liedtke, Cornelia, MD, Minckwitz, Gunter von, Prof, Nekljudova, Valentina, PhD, Schmatloch, Sabine, MD, Schrenk, Peter, MD, Staebler, Annette, MD, Untch, Michael, Prof

Get full text

2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial by Goldhirsch, Aron, Prof, Gelber, Richard D, Prof, Piccart-Gebhart, Martine J, Prof, de Azambuja, Evandro, MD, Procter, Marion, MSci, Suter, Thomas M, Prof, Jackisch, Christian, Prof, Cameron, David, Prof, Weber, Harald A, MD, Heinzmann, Dominik, PhD, Lago, Lissandra Dal, MD, McFadden, Eleanor, MA, Dowsett, Mitch, Prof, Untch, Michael, Prof, Gianni, Luca, MD, Bell, Richard, Prof, Köhne, Claus-Henning, Prof, Vindevoghel, Anita, MD, Andersson, Michael, MD, Brunt, A Murray, MD, Otero-Reyes, Douglas, MD, Song, Santai, MD, Smith, Ian, Prof, Leyland-Jones, Brian, PhD, Baselga, Jose, Prof

Get full text

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial by Gianni, Luca, Prof, Dafni, Urania, Prof, Gelber, Richard D, Prof, Azambuja, Evandro, PhD, Muehlbauer, Susanne, PhD, Goldhirsch, Aron, Prof, Untch, Michael, Prof, Smith, Ian, Prof, Baselga, José, Prof, Jackisch, Christian, Prof, Cameron, David, Prof, Mano, Max, MD, Pedrini, José Luiz, MD, Veronesi, Andrea, Prof, Mendiola, Cesar, MD, Pluzanska, Anna, Prof, Semiglazov, Vladimir, MD, Vrdoljak, Eduard, MD, Eckart, Michael J, MD, Shen, Zhenzhou, Prof, Skiadopoulos, George, MSci, Procter, Marion, MSci, Pritchard, Kathleen I, MD, Piccart-Gebhart, Martine J, PhD, Bell, Richard, MBBS

Get full text

Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial by Untch, Michael, Prof, Loibl, Sibylle, MD, Bischoff, Joachim, MD, Eidtmann, Holger, MD, Kaufmann, Manfred, Prof, Blohmer, Jens-Uwe, Prof, Hilfrich, Jörn, Prof, Strumberg, Dirk, Prof, Fasching, Peter A, Prof, Kreienberg, Rolf, Prof, Tesch, Hans, Prof, Hanusch, Claus, MD, Gerber, Bernd, Prof, Rezai, Mahdi, MD, Jackisch, Christian, Prof, Huober, Jens, Prof, Kühn, Thorsten, Prof, Nekljudova, Valentina, PhD, von Minckwitz, Gunter, Prof

Get full text

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial by Smith, Ian, Prof, Procter, Marion, MSci, Gelber, Richard D, Prof, Guillaume, Sébastien, MSc, Feyereislova, Andrea, MD, Dowsett, Mitch, Prof, Goldhirsch, Aron, Prof, Untch, Michael, Prof, Mariani, Gabriella, MD, Baselga, Jose, Prof, Kaufmann, Manfred, Prof, Cameron, David, MD, Bell, Richard, Prof, Bergh, Jonas, Prof, Coleman, Robert, Prof, Wardley, Andrew, MD, Harbeck, Nadia, Prof, Lopez, Roberto I, MD, Mallmann, Peter, Prof, Gelmon, Karen, Prof, Wilcken, Nicholas, PhD, Wist, Erik, Prof, Sánchez Rovira, Pedro, MD, Piccart-Gebhart, Martine J, Prof

Get full text

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials by Bohlius, Julia, MD, Schmidlin, Kurt, DMD, Brillant, Corinne, MSc, Schwarzer, Guido, PhD, Trelle, Sven, MD, Seidenfeld, Jerome, PhD, Zwahlen, Marcel, PhD, Clarke, Michael, Prof, Weingart, Olaf, MD, Kluge, Sabine, MA, Piper, Margaret, PhD, Rades, Dirk, MD, Steensma, David P, MD, Djulbegovic, Benjamin, Prof, Fey, Martin F, Prof, Ray-Coquard, Isabelle, MD, Machtay, Mitchell, Prof, Moebus, Volker, Prof, Thomas, Gillian, Prof, Untch, Michael, Prof, Schumacher, Martin, Prof, Egger, Matthias, Prof, Engert, Andreas, Prof

Get full text

11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial by Cameron, David, Prof, Piccart-Gebhart, Martine J, PhD, Gelber, Richard D, PhD, Procter, Marion, PhD, Goldhirsch, Aron, MD, de Azambuja, Evandro, MD, Castro, Gilberto, MD, Untch, Michael, MD, Smith, Ian, MD, Gianni, Luca, MD, Baselga, Jose, MD, Al-Sakaff, Nedal, PhD, Lauer, Sabine, PhD, McFadden, Eleanor, MA, Leyland-Jones, Brian, MBBS, Bell, Richard, MBBS, Dowsett, Mitch, PhD, Jackisch, Christian, MD

Get full text

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis by Cortazar, Patricia, Dr, Zhang, Lijun, PhD, Untch, Michael, Prof, Mehta, Keyur, MBA, Costantino, Joseph P, DrPH, Wolmark, Norman, MD, Bonnefoi, Hervé, Prof, Cameron, David, Prof, Gianni, Luca, Prof, Valagussa, Pinuccia, BS, Swain, Sandra M, MD, Prowell, Tatiana, MD, Loibl, Sibylle, Prof, Wickerham, D Lawrence, MD, Bogaerts, Jan, PhD, Baselga, Jose, Prof, Perou, Charles, PhD, Blumenthal, Gideon, MD, Blohmer, Jens, Prof, Mamounas, Eleftherios P, MD, Bergh, Jonas, Prof, Semiglazov, Vladimir, Prof, Justice, Robert, MD, Eidtmann, Holger, MD, Paik, Soonmyung, MD, Piccart, Martine, Prof, Sridhara, Rajeshwari, PhD, Fasching, Peter A, Prof, Slaets, Leen, PhD, Tang, Shenghui, PhD, Gerber, Bernd, Prof, Geyer, Charles E, MD, Pazdur, Richard, MD, Ditsch, Nina, MD, Rastogi, Priya, MD, Eiermann, Wolfgang, Prof, von Minckwitz, Gunter, Prof

Get full text